Male = 88; Female = 57 | Median | Mean ± SD | Range | Skewness | Kurtosis |
Age | 67.5 | 67.1 ± 10 | 52 | −0.36 | 0.15 |
Education | 8 | 9 ± 4.5 | 21 | 0.92 | 0.42 |
Years of disease | 6 | 8.38 ± 6.5 | 26.3 | 1.15 | 0.73 |
Years with l-dopa | 6 | 6.2 ± 4.5 | 18 | 0.65 | −0.15 |
Dose | 750 | 692.8 ± 312.3 | 1250 | −0.50 | 0.17 |
SPES-SCOPA 1 | 16 | 17.1 ± 5.2 | 25 | 0.27 | −0.09 |
SPES-SCOPA 2 | 8 | 9.4 ± 3.6 | 19 | 0.76 | 0.67 |
SPES-SCOPA 3 | 2 | 3.3 ± 3.3 | 12 | 0.88 | −0.11 |
SPES-SCOPA Total | 28 | 29.9 ± 10.8 | 51 | 0.55 | −0.01 |
Schwab & England | 70 | 70.3 ± 16.2 | 80 | −1.13 | 1.22 |
MMSE | 29 | 27.5 ± 3.4 | 19 | −2.55 | 8.10 |
Clox-1 | 11 | 9.8 ± 3.4 | 15 | −0.75 | 0.03 |
Clox-2 | 13 | 12.7 ± 2.6 | 13 | −1.93 | 4.50 |
HADS anxiety | 9 | 8.7 ± 4.1 | 18 | −0.16 | −0.60 |
HADS depression | 8 | 7.8 ± 3.7 | 16 | 0.30 | −0.32 |
PIMS | 19 | 18.8 ± 8.7 | 38 | 0.10 | −0.55 |
SCOPA P-S | 12.5 | 11.8 ± 6.1 | 22 | 0.14 | −1.17 |
CISI-PD | 11 | 11.1 ± 4.2 | 18 | 0.36 | −0.27 |